Poll
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Top 5 urologic oncology headlines you missed in July 2025
Pembrolizumab plus axitinib shows sustained benefit vs sunitinib in ccRCC
Metastasis-directed radiotherapy without systemic therapy yields promising outcomes in oligometastatic ccRCC
What urologists can expect in Q3 of 2025
Pivotal trial of histotripsy system for kidney tumors reaches enrollment goal
Sintilimab plus fruquintinib under review in China for advanced renal cell carcinoma
What should the adult urologist know about pediatric urologic cancers?
FDA grants de novo authorization to ArteraAI Prostate
FDA grants priority review to gepotidacin for uncomplicated urogenital gonorrhea
Pearls & Perspectives: Bringing the Magic Back to Medicine, with David Canes, MD